Clinical Trials Browser

Not yet recruiting × Surgical Procedures, Operative × Thoracic × Clear all

NCT06743555 2026-04-28

SAVED LUNG

Phase 1 Not yet recruiting

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT07472478 2026-03-16

GIVEN

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07432802 2026-02-27

STRADOS

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07241819 2025-11-21

Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer

NCT07177092 2025-09-16

SURGAN-TKI

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07089199 2025-07-28

TitAN

Phase 2 Not yet recruiting

NSCLC

NCT07038460 2025-06-26

NEO-LISI

Phase 2 Not yet recruiting

Resectable Non-small Cell Lung Cancer

NCT06998719 2025-05-31

ACCESS

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06944470 2025-04-25

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

Phase 2 Not yet recruiting

NSCLC

NCT06837948 2025-02-20

Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC

Phase 2 Not yet recruiting

Locally Advanced Non-Small Cell Lung Cancer

NCT06591910 2024-09-19

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06282536 2024-02-28

Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06109402 2023-12-19

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05891080 2023-06-06

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05496166 2023-05-17

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

Limited Stage Small Cell Lung Cancer

NCT04465968 2020-07-10

DEEP_OCEAN

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Pancoast Syndrome